pdf

O’Melveny’s Anderson Quoted in Law360 on Challenges to State AG Contingency Fee Agreements

June 18, 2012

O’Melveny & Myers LLP partner Brian Anderson is quoted in the June 15, 2012, Law360 article, “Statehouse The Place To Tackle AG Fee Deals, Experts Say.” The article reports that contingency fee agreements between state attorneys general and private attorneys to sue corporations are increasingly being challenged. GlaxoSmithKline PLC, Merck & Co. Inc. and AstraZeneca Pharmaceuticals LP have each brought constitutional challenges against the practice, according to Law360.

“Given how many of these cases there are, sooner or later, they’re going to be reined in, in some fashion,” Anderson said. “It’s morphed to the point where too many attorneys general, rather than going to work every day and trying to pursue justice for the interest of their states, are reading the newspaper looking for out-of-state companies they can sue, in order to generate windfall recoveries for their state that they control and provide remuneration to attorneys that help put them in office,” he added. “That’s a perversion of justice.”

Anderson is a member of O'Melveny's Class Actions, Mass Torts & Insurance Litigation Practice and resides in the Firm's Washington, DC office.